MacroGenics to Participate in Upcoming Investor Conferences
March 01, 2024 17:48 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, March 01, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
MacroGenics to Participate in Upcoming Investor Conference
February 02, 2024 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Feb. 02, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
MacroGenics to Participate in Upcoming Investor Conference
January 08, 2024 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
MacroGenics to Participate in Upcoming Investor Conferences
November 02, 2023 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Nov. 02, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
MacroGenics to Participate in Upcoming Investor Conferences
August 31, 2023 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Aug. 31, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference
July 27, 2023 08:00 ET
|
Avalyn Pharma Inc.
SEATTLE , July 27, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies for life-threatening pulmonary diseases,...
MacroGenics to Participate in Upcoming Investor Conferences
April 24, 2023 18:15 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, April 24, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for...
Standard Lithium to Present at the Echelon Partners Lithium Summit April 13, 2023
April 11, 2023 17:53 ET
|
Standard Lithium
VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), a leading near-commercial lithium...
MacroGenics to Participate in Upcoming Investor Conferences
March 02, 2023 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, March 02, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for...
Standard Lithium to Participate in the BMO 32nd Global Metals, Mining & Critical Minerals Conference
February 23, 2023 16:01 ET
|
Standard Lithium
VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), a leading near-commercial lithium...